Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System
Kim M. A. De Kleijn, Gerard J.M. Martens
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4229-4229
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 47
Regulatory Cells in Multiple Sclerosis: From Blood to Brain
Leticia Calahorra, Celia Camacho-Toledano, Mari Paz Serrano‐Regal, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 335-335
Open Access | Times Cited: 39
Central nervous system demyelinating diseases: glial cells at the hub of pathology
Vinicius Gabriel Coutinho Costa, Sheila Espírito-Santo Araújo, Soniza Vieira Alves‐Leon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Alberto Santiago-Balmaseda, Annai Aguirre-Orozco, Irais E. Valenzuela-Arzeta, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 921-921
Open Access | Times Cited: 10
Microneedle/CD-MOF-mediated transdural controlled release of methylprednisolone sodium succinate after spinal cord injury
Xiao Zhai, Kai Chen, Xianzhao Wei, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 236-248
Closed Access | Times Cited: 20
Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis
Martina Kunkl, Carola Amormino, Valentina Tedeschi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)
Dennis L. Kolson
Current HIV/AIDS Reports (2022) Vol. 19, Iss. 5, pp. 344-357
Open Access | Times Cited: 25
Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study
Zejin Liu, Xinli Niu, Junpeng Wang
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 32, pp. 11026-11043
Closed Access | Times Cited: 20
Recent insights into astrocytes as therapeutic targets for demyelinating diseases
Rianne P. Gorter, Wia Baron
Current Opinion in Pharmacology (2022) Vol. 65, pp. 102261-102261
Open Access | Times Cited: 16
Antidepressant effect of teriflunomide via oligodendrocyte protection in a mouse model
Shuting Luo, Feilong Wu, Fang Qian, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29481-e29481
Open Access | Times Cited: 2
Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
S Rehan Ahmad, Md. Zeyaullah, Abdullah M. AlShahrani, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4, pp. 142-142
Open Access | Times Cited: 2
FTY720 Reduces the Biomass of Biofilms in Pseudomonas aeruginosa in a Dose-Dependent Manner
Abdurahman A. Niazy, Rhodanne Lambarte, Terrence S. Sumague, et al.
Antibiotics (2024) Vol. 13, Iss. 7, pp. 621-621
Open Access | Times Cited: 2
Inhibition of Microglial Activation by Amitriptyline and Doxepin in Interferon-β Pre-Treated Astrocyte–Microglia Co-Culture Model of Inflammation
Timo Jendrik Faustmann, Marisa Wawrzyniak, Pedro M. Faustmann, et al.
Brain Sciences (2023) Vol. 13, Iss. 3, pp. 493-493
Open Access | Times Cited: 5
Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2′-deoxyguanosine in patients with multiple sclerosis
Negin Bodaghi Khajenobar, Soltanali Mahboob, Alireza Nourazarian, et al.
Clinical Neurology and Neurosurgery (2020) Vol. 200, pp. 106377-106377
Closed Access | Times Cited: 13
Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control study
Laura Moles, Ane Otaegui-Chivite, Miriam Gorostidi-Aicua, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 6, pp. e00457-e00457
Open Access | Times Cited: 1
Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders
María Laura Palumbo, Alejandro David Moroni, Sofía Quiroga, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 10
Effects Mediated by Dimethyl Fumarate on In Vitro Oligodendrocytes: Implications in Multiple Sclerosis
Claudia Guerriero, Giulia Puliatti, Tamara Di Marino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3615-3615
Open Access | Times Cited: 7
Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis
Nik Krajnc, Gabriel Bsteh, Gregor Kasprian, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 6
Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study
Martha Rocio Hernández-Preciado, Jazmín Márquez-Pedroza, Nayeli Alejandra Sánchez-Rosales, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3584-3584
Open Access | Times Cited: 5
Superoxide Dismutase-1 Intracellular Content in T Lymphocytes Associates with Increased Regulatory T Cell Level in Multiple Sclerosis Subjects Undergoing Immune-Modulating Treatment
Valentina Rubino, Anna Teresa Palatucci, Giuliana La Rosa, et al.
Antioxidants (2021) Vol. 10, Iss. 12, pp. 1940-1940
Open Access | Times Cited: 7
Use of Cells, Supplements and Peptides as Therapeutic Strategies for Modulating Inflammation after Spinal Cord Injury: An Update
Elisa García, Vinnitsa Buzoianu-Anguiano, Raúl Silva García, et al.
(2023)
Open Access | Times Cited: 2
MMF induces antioxidative and anaplerotic pathways and is neuroprotective in hyperexcitability in vitro
Lukas Gola, Laura Bierhansl, Nicolas Hummel, et al.
Free Radical Biology and Medicine (2022) Vol. 194, pp. 337-346
Closed Access | Times Cited: 4
Teriflunomide provides protective properties after oxygen-glucose-deprivation in hippocampal and cerebellar slice cultures
Veronika Matschke, Anna Wolters, J Reuther, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 11, pp. 2243-2243
Open Access | Times Cited: 4
Case Report: Rapid Desensitization to Ocrelizumab for Multiple Sclerosis Is Effective and Safe
Marcelo Vívolo Aun, Fernando Freua, Victor Hugo Rocha Marussi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 3
Molecular insights of T-2 toxin exposure-induced neurotoxicity and the neuroprotective effect of dimethyl fumarate
Xingyao Pei, Shuhui Ma, Hong Liang, et al.
Food and Chemical Toxicology (2024), pp. 115166-115166
Closed Access
Page 1 - Next Page

Scroll to top